<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<style>body{background-color:white;}</style>


</head>
<body>
<div id="jxzsstipzk" style="padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
  <style>html {
  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;
}

#jxzsstipzk .gt_table {
  display: table;
  border-collapse: collapse;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#jxzsstipzk .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#jxzsstipzk .gt_caption {
  padding-top: 4px;
  padding-bottom: 4px;
}

#jxzsstipzk .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#jxzsstipzk .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 0;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#jxzsstipzk .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#jxzsstipzk .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#jxzsstipzk .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#jxzsstipzk .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#jxzsstipzk .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#jxzsstipzk .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#jxzsstipzk .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#jxzsstipzk .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  text-align: left;
}

#jxzsstipzk .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#jxzsstipzk .gt_from_md > :first-child {
  margin-top: 0;
}

#jxzsstipzk .gt_from_md > :last-child {
  margin-bottom: 0;
}

#jxzsstipzk .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#jxzsstipzk .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#jxzsstipzk .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#jxzsstipzk .gt_row_group_first td {
  border-top-width: 2px;
}

#jxzsstipzk .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#jxzsstipzk .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#jxzsstipzk .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#jxzsstipzk .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#jxzsstipzk .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#jxzsstipzk .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#jxzsstipzk .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#jxzsstipzk .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#jxzsstipzk .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#jxzsstipzk .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-left: 4px;
  padding-right: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#jxzsstipzk .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#jxzsstipzk .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#jxzsstipzk .gt_left {
  text-align: left;
}

#jxzsstipzk .gt_center {
  text-align: center;
}

#jxzsstipzk .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#jxzsstipzk .gt_font_normal {
  font-weight: normal;
}

#jxzsstipzk .gt_font_bold {
  font-weight: bold;
}

#jxzsstipzk .gt_font_italic {
  font-style: italic;
}

#jxzsstipzk .gt_super {
  font-size: 65%;
}

#jxzsstipzk .gt_footnote_marks {
  font-style: italic;
  font-weight: normal;
  font-size: 75%;
  vertical-align: 0.4em;
}

#jxzsstipzk .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#jxzsstipzk .gt_indent_1 {
  text-indent: 5px;
}

#jxzsstipzk .gt_indent_2 {
  text-indent: 10px;
}

#jxzsstipzk .gt_indent_3 {
  text-indent: 15px;
}

#jxzsstipzk .gt_indent_4 {
  text-indent: 20px;
}

#jxzsstipzk .gt_indent_5 {
  text-indent: 25px;
}
</style>
  <table class="gt_table" style="table-layout: fixed;; width: 100%">
  <colgroup>
    <col style="width:30%;"/>
    <col style="width:11.3333333333333%;"/>
    <col style="width:6%;"/>
    <col style="width:11.3333333333333%;"/>
    <col style="width:6%;"/>
    <col style="width:11.3333333333333%;"/>
    <col style="width:6%;"/>
    <col style="width:9%;"/>
    <col style="width:9%;"/>
  </colgroup>
  <thead class="gt_header">
    <tr>
      <td colspan="9" class="gt_heading gt_title gt_font_normal" style>Table 14-5.01</td>
    </tr>
    <tr>
      <td colspan="9" class="gt_heading gt_subtitle gt_font_normal gt_bottom_border" style>Incidence of Treatment Emergent Adverse Events by Treatment Group</td>
    </tr>
  </thead>
  <thead class="gt_col_headings">
    <tr>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="2" colspan="1" scope="col" id="label">label</th>
      <th class="gt_center gt_columns_top_border gt_column_spanner_outer" rowspan="1" colspan="2" scope="colgroup" id="Placebo&lt;br /&gt;&#10;(N=86)">
        <span class="gt_column_spanner">Placebo<br />
(N=86)</span>
      </th>
      <th class="gt_center gt_columns_top_border gt_column_spanner_outer" rowspan="1" colspan="2" scope="colgroup" id="Xanomeline&lt;br /&gt;&#10;Low Dose&lt;br /&gt;&#10;(N=84)">
        <span class="gt_column_spanner">Xanomeline<br />
Low Dose<br />
(N=84)</span>
      </th>
      <th class="gt_center gt_columns_top_border gt_column_spanner_outer" rowspan="1" colspan="2" scope="colgroup" id="Xanomeline&lt;br /&gt;&#10;High Dose&lt;br /&gt;&#10;(N=84)">
        <span class="gt_column_spanner">Xanomeline<br />
High Dose<br />
(N=84)</span>
      </th>
      <th class="gt_center gt_columns_top_border gt_column_spanner_outer" rowspan="1" colspan="2" scope="colgroup" id="Fisher's Exact&lt;br /&gt;&#10;p-values">
        <span class="gt_column_spanner">Fisher's Exact<br />
p-values</span>
      </th>
    </tr>
    <tr>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="n(%)">n(%)</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="[AEs]">[AEs]</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="n(%)">n(%)</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="[AEs]">[AEs]</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="n(%)">n(%)</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="[AEs]">[AEs]</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="Placebo&lt;br /&gt;&#10;vs.&lt;br /&gt;&#10;Low Dose">Placebo<br />
vs.<br />
Low Dose</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1" scope="col" id="Placebo&lt;br /&gt;&#10;vs.&lt;br /&gt;&#10;High Dose">Placebo<br />
vs.<br />
High Dose</th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td headers="label" class="gt_row gt_left">  ANY BODY SYSTEM</td>
<td headers="placebo_n" class="gt_row gt_right">65 (75.6%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[281]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">77 (91.7%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[412]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">76 (90.5%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[433]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.007*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.014*</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  CARDIAC DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">12 (14.0%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[26]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">13 (15.5%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[30]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">15 (17.9%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[30]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.831</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.534</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SINUS BRADYCARDIA</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">7 (8.3%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[10]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">8 (9.5%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[12]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.097*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.056*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    MYOCARDIAL INFARCTION</td>
<td headers="placebo_n" class="gt_row gt_right">4 (4.7%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[8]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.682</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ATRIAL FIBRILLATION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[5]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.365</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ATRIAL FLUTTER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CARDIAC DISORDER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SUPRAVENTRICULAR EXTRASYSTOLES</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VENTRICULAR EXTRASYSTOLES</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.243</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ATRIAL HYPERTROPHY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ATRIOVENTRICULAR BLOCK FIRST DEGREE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ATRIOVENTRICULAR BLOCK SECOND DEGREE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BRADYCARDIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BUNDLE BRANCH BLOCK LEFT</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BUNDLE BRANCH BLOCK RIGHT</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CARDIAC FAILURE CONGESTIVE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PALPITATIONS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.243</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SINUS ARRHYTHMIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SUPRAVENTRICULAR TACHYCARDIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    TACHYCARDIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VENTRICULAR HYPERTROPHY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    WOLFF-PARKINSON-WHITE SYNDROME</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  CONGENITAL, FAMILIAL AND GENETIC DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VENTRICULAR SEPTAL DEFECT</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  EAR AND LABYRINTH DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.618</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VERTIGO</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CERUMEN IMPACTION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EAR PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  EYE DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VISION BLURRED</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CONJUNCTIVAL HAEMORRHAGE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CONJUNCTIVITIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EYE ALLERGY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EYE PRURITUS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EYE SWELLING</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  GASTROINTESTINAL DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">17 (19.8%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[26]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">14 (16.7%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[22]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">20 (23.8%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[36]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.692</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.580</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VOMITING</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">7 (8.3%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[9]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.208</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    NAUSEA</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">6 (7.1%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[13]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.326</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DIARRHOEA</td>
<td headers="placebo_n" class="gt_row gt_right">9 (10.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[10]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[4]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.248</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.248</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SALIVARY HYPERSECRETION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[5]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.057*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ABDOMINAL DISCOMFORT</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ABDOMINAL PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.365</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    GASTROINTESTINAL HAEMORRHAGE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    STOMACH DISCOMFORT</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CONSTIPATION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DYSPEPSIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DYSPHAGIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FLATULENCE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    GASTROOESOPHAGEAL REFLUX DISEASE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    GLOSSITIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HIATUS HERNIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RECTAL HAEMORRHAGE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS</td>
<td headers="placebo_n" class="gt_row gt_right">21 (24.4%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[46]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">47 (56.0%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[118]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">40 (47.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[124]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.000*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.002*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE PRURITUS</td>
<td headers="placebo_n" class="gt_row gt_right">6 (7.0%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[10]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">22 (26.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[32]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">22 (26.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[35]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.001*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.001*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE ERYTHEMA</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">12 (14.3%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[20]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">15 (17.9%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[23]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.015*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.002*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE IRRITATION</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[7]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">9 (10.7%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[18]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">9 (10.7%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[16]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.078*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.078*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE DERMATITIS</td>
<td headers="placebo_n" class="gt_row gt_right">5 (5.8%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[9]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">9 (10.7%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[15]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">7 (8.3%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[12]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.277</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.563</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE VESICLES</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">6 (7.1%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[6]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.208</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.062*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FATIGUE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[5]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.115*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.115*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE PERSPIRATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[3]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE SWELLING</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[3]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CHEST DISCOMFORT</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CHEST PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    MALAISE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[3]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    OEDEMA PERIPHERAL</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[3]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE DISCHARGE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE REACTION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE URTICARIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.243</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ASTHENIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CHILLS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FEELING ABNORMAL</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FEELING COLD</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PYREXIA</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.497</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE BLEEDING</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE DESQUAMATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE DISCOLOURATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE INDURATION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    APPLICATION SITE WARMTH</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    INFLAMMATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    OEDEMA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.243</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SECRETION DISCHARGE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SUDDEN DEATH</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SWELLING</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ULCER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  HEPATOBILIARY DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HYPERBILIRUBINAEMIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  IMMUNE SYSTEM DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HYPERSENSITIVITY</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  INFECTIONS AND INFESTATIONS</td>
<td headers="placebo_n" class="gt_row gt_right">16 (18.6%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[35]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">9 (10.7%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[16]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">13 (15.5%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[20]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.194*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.685</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    NASOPHARYNGITIS</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[9]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">6 (7.1%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[8]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.441</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.166*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    UPPER RESPIRATORY TRACT INFECTION</td>
<td headers="placebo_n" class="gt_row gt_right">6 (7.0%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[12]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[5]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.117*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.496</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CYSTITIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HORDEOLUM</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    INFLUENZA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    LOWER RESPIRATORY TRACT INFECTION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RHINITIS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    URINARY TRACT INFECTION</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.497</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BRONCHITIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CELLULITIS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CERVICITIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EAR INFECTION</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.497</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.497</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    GASTROENTERITIS VIRAL</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    LOCALISED INFECTION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PNEUMONIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VAGINAL MYCOSIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    VIRAL INFECTION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  INJURY, POISONING AND PROCEDURAL COMPLICATIONS</td>
<td headers="placebo_n" class="gt_row gt_right">4 (4.7%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[9]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[12]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[8]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.745</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.745</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CONTUSION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[3]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.618</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HIP FRACTURE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.618</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EXCORIATION</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FACIAL BONES FRACTURE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FALL</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.618</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    JOINT DISLOCATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SKIN LACERATION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.618</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    WOUND</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  INVESTIGATIONS</td>
<td headers="placebo_n" class="gt_row gt_right">10 (11.6%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[19]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">6 (7.1%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[7]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">6 (7.1%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[8]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.432</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.432</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BIOPSY</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BIOPSY PROSTATE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BLOOD CHOLESTEROL INCREASED</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BLOOD GLUCOSE INCREASED</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ELECTROCARDIOGRAM T WAVE INVERSION</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    WEIGHT DECREASED</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BLOOD ALKALINE PHOSPHATASE INCREASED</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BLOOD CREATINE PHOSPHOKINASE INCREASED</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BLOOD URINE PRESENT</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BODY TEMPERATURE INCREASED</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CYSTOSCOPY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ELECTROCARDIOGRAM ST SEGMENT DEPRESSION</td>
<td headers="placebo_n" class="gt_row gt_right">4 (4.7%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.368</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.121*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HEART RATE INCREASED</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HEART RATE IRREGULAR</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    NASAL MUCOSA BIOPSY</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  METABOLISM AND NUTRITION DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">6 (7.0%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[8]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[4]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.117*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.278</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DECREASED APPETITE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    INCREASED APPETITE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DEHYDRATION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DIABETES MELLITUS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FOOD CRAVING</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HYPONATRAEMIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">4 (4.7%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[6]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">7 (8.3%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[10]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">7 (8.3%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[10]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.367</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.367</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BACK PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[4]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.365</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ARTHRALGIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.618</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ARTHRITIS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    FLANK PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    MUSCLE SPASMS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    MYALGIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    MUSCULAR WEAKNESS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PAIN IN EXTREMITY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SHOULDER PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.618</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.243</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PROSTATE CANCER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    COLON CANCER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    MALIGNANT FIBROUS HISTIOCYTOMA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  NERVOUS SYSTEM DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">8 (9.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[11]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">20 (23.8%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[40]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">25 (29.8%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[41]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.013*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.001*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DIZZINESS</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">8 (9.5%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[13]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">11 (13.1%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[15]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.056*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.009*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HEADACHE</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[8]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.493</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SYNCOPE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[6]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[4]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.057*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.118*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BURNING SENSATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    AMNESIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    COGNITIVE DISORDER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HYPERSOMNIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    LETHARGY</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PARAESTHESIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PAROSMIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PARTIAL SEIZURES WITH SECONDARY GENERALISATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SOMNOLENCE</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.680</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SYNCOPE VASOVAGAL</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    TRANSIENT ISCHAEMIC ATTACK</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.243</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BALANCE DISORDER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    COMPLEX PARTIAL SEIZURES</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    COORDINATION ABNORMAL</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HEMIANOPIA HOMONYMOUS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PARAESTHESIA ORAL</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PARKINSON'S DISEASE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PSYCHOMOTOR HYPERACTIVITY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    STUPOR</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  PSYCHIATRIC DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">10 (11.6%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[12]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">10 (11.9%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[14]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">8 (9.5%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[11]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.804</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    INSOMNIA</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.497</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    AGITATION</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CONFUSIONAL STATE</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.680</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DELIRIUM</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DELUSION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HALLUCINATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HALLUCINATION, VISUAL</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    LIBIDO DECREASED</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    LISTLESS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    NIGHTMARE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ANXIETY</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.118*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    COMPLETED SUICIDE</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DEPRESSED MOOD</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DISORIENTATION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    IRRITABILITY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RESTLESSNESS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  RENAL AND URINARY DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">4 (4.7%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[4]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CALCULUS URETHRAL</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    MICTURITION URGENCY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    NEPHROLITHIASIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DYSURIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    INCONTINENCE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    POLLAKIURIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  REPRODUCTIVE SYSTEM AND BREAST DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.497</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BENIGN PROSTATIC HYPERPLASIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PELVIC PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">8 (9.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[12]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">9 (10.7%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[14]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">10 (11.9%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[22]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.803</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.626</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    COUGH</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[7]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[7]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.115*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.115*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    NASAL CONGESTION</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[4]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.621</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EPISTAXIS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ALLERGIC GRANULOMATOUS ANGIITIS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DYSPNOEA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PHARYNGEAL ERYTHEMA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PHARYNGOLARYNGEAL PAIN</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PRODUCTIVE COUGH</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RESPIRATORY TRACT CONGESTION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RHINORRHOEA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DYSPHONIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EMPHYSEMA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HAEMOPTYSIS</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    POSTNASAL DRIP</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RALES</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  SKIN AND SUBCUTANEOUS TISSUE DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">20 (23.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[45]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">39 (46.4%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[111]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">40 (47.6%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[104]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.002*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.001*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PRURITUS</td>
<td headers="placebo_n" class="gt_row gt_right">8 (9.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[11]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">21 (25.0%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[31]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">26 (31.0%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[38]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.008*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.000*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ERYTHEMA</td>
<td headers="placebo_n" class="gt_row gt_right">8 (9.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[12]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">14 (16.7%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[22]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">14 (16.7%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[22]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.175*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.175*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RASH</td>
<td headers="placebo_n" class="gt_row gt_right">5 (5.8%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[9]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">13 (15.5%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[18]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">9 (10.7%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[15]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.048*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.277</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HYPERHIDROSIS</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">4 (4.8%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[5]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">8 (9.5%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[10]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.441</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.056*</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SKIN IRRITATION</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">6 (7.1%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[13]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[8]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.326</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.493</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RASH PRURITIC</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[3]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.243</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ACTINIC KERATOSIS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    BLISTER</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">5 (6.0%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[8]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.028*</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    PRURITUS GENERALISED</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[4]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RASH MACULO-PAPULAR</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SKIN ODOUR ABNORMAL</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    URTICARIA</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ALOPECIA</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    COLD SWEAT</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DERMATITIS CONTACT</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    DRUG ERUPTION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    RASH ERYTHEMATOUS</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SKIN EXFOLIATION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SKIN ULCER</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  SOCIAL CIRCUMSTANCES</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ALCOHOL USE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  SURGICAL AND MEDICAL PROCEDURES</td>
<td headers="placebo_n" class="gt_row gt_right">2</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">2 (2.4%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[2]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ACROCHORDON EXCISION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    SKIN LESION EXCISION</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    CATARACT OPERATION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    EYE LASER SURGERY</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left"></td>
<td headers="placebo_n" class="gt_row gt_right"></td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">  VASCULAR DISORDERS</td>
<td headers="placebo_n" class="gt_row gt_right">3 (3.5%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[7]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">3 (3.6%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.621</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    WOUND HAEMORRHAGE</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right">[1]</td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.494</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HOT FLUSH</td>
<td headers="placebo_n" class="gt_row gt_right">0</td>
<td headers="placebo_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">0.494</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right"></td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HYPERTENSION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    HYPOTENSION</td>
<td headers="placebo_n" class="gt_row gt_right">2 (2.3%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[3]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right">[1]</td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">0.497</td></tr>
    <tr><td headers="label" class="gt_row gt_left">    ORTHOSTATIC HYPOTENSION</td>
<td headers="placebo_n" class="gt_row gt_right">1 (1.2%)</td>
<td headers="placebo_ae" class="gt_row gt_right">[2]</td>
<td headers="xanomeline_ld_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_ld_ae" class="gt_row gt_right"></td>
<td headers="xanomeline_hd_n" class="gt_row gt_right">0</td>
<td headers="xanomeline_hd_ae" class="gt_row gt_right"></td>
<td headers="fisher_placebo_v_xanomeline_ld" class="gt_row gt_right">>.99</td>
<td headers="fisher_placebo_v_xanomeline_hd" class="gt_row gt_right">>.99</td></tr>
  </tbody>
  <tfoot class="gt_sourcenotes">
    <tr>
      <td class="gt_sourcenote" colspan="9">Program Source: t-14-5-01.R     Executed: (Draft) 2022-12-01</td>
    </tr>
  </tfoot>
  <tfoot class="gt_footnotes">
    <tr>
      <td class="gt_footnote" colspan="9"> Note: Treatment emergent events are defined as events which start on or after the start of treatment.</td>
    </tr>
    <tr>
      <td class="gt_footnote" colspan="9"> Note: Adverse events are coded using MedDRA.</td>
    </tr>
    <tr>
      <td class="gt_footnote" colspan="9"> Note: Percentages are based on the number of subjects in the safety population within each treatment group.</td>
    </tr>
    <tr>
      <td class="gt_footnote" colspan="9"> Note: P-values are based on Fisher's Exact test for the comparison of placebo versus each active treatment group. An asterisk is appended to p-values that are less than 0.15.</td>
    </tr>
    <tr>
      <td class="gt_footnote" colspan="9"> Note: The column [AE] represents the total number of times an event was recorded.</td>
    </tr>
  </tfoot>
</table>
</div>
</body>
</html>
